Discovery of small molecule inhibitors of Leishmania braziliensis Hsp90 chaperone

References

• Nii-Trebi NI. Emerging and neglected infectious diseases: insights, advances, and challenges. Biomed Res Int 2017;2017:1–15.
   Web of Science ®Google Scholar
• Alcantara LM, Ferreira TCS, Gadelha FR, Miguel DC. Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis. Int J Parasitol Drugs Drug Resist 2018;8:430–9.
   PubMed Web of Science ®Google Scholar
• Alvar J, Vélez ID, Bern C, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE 2012;7:e35671.
   PubMed Web of Science ®Google Scholar
• Varikuti S, Jha BK, Volpedo G, et al. Host-directed drug therapies for neglected tropical diseases caused by protozoan parasites. Front Microbiol 2018;9:2655.
   PubMed Web of Science ®Google Scholar
• Hombach A, Clos J. No stress – Hsp90 and signal transduction in Leishmania. Parasitology 2014;141:1156–66.
   PubMed Web of Science ®Google Scholar
• Graefe SE, Wiesgigl M, Gaworski I, et al. Inhibition of HSP90 in Trypanosoma cruzi induces a stress response but no stage differentiation. Eukaryot Cell 2002;1:936–43.
   PubMedGoogle Scholar
• Seraphim TV, Ramos CHI, Borges JC, The interaction networks of Hsp70 and Hsp90 in the Plasmodium and Leishmania parasites. In: Houry W, ed. The molecular chaperones interaction networks in protein folding and degradation. Interactomics and systems biology. 1. New York: Springer; 2014:445–81.
   Google Scholar
• Wandinger SK, Richter K, Buchner J. The Hsp90 chaperone machinery. J Biol Chem 2008;283:18473–7.
   PubMed Web of Science ®Google Scholar
• Sahasrabudhe P, Rohrberg J, Biebl MM, et al. The plasticity of the Hsp90 Co-chaperone system. Mol Cell 2017;67:947–61 e5.
   PubMed Web of Science ®Google Scholar
• Schopf FH, Biebl MM, Buchner J. The HSP90 chaperone machinery. Nat Rev Mol Cell Biol 2017;18:345–60.
   PubMed Web of Science ®Google Scholar
• Pallavi R, Roy N, Nageshan RK, et al. Heat shock protein 90 as a drug target against protozoan infections: biochemical characterization of HSP90 from Plasmodium falciparum and Trypanosoma evansi and evaluation of its inhibitor as a candidate drug. J Biol Chem 2010;285:37964–75.
   PubMed Web of Science ®Google Scholar
• Soti C, Nagy E, Giricz Z, et al. Heat shock proteins as emerging therapeutic targets. Br J Pharmacol 2005;146:769–80.
   PubMed Web of Science ®Google Scholar
• Powers MV, Workman P. Inhibitors of the heat shock response: biology and pharmacology. FEBS Lett 2007;581:3758–69.
   PubMed Web of Science ®Google Scholar
• Giannini G, Battistuzzi G. Exploring in vitro and in vivo Hsp90 inhibitors activity against human protozoan parasites. Bioorg Med Chem Lett 2015;25:462–5.
   PubMed Web of Science ®Google Scholar
• Sidera K, Patsavoudi E. HSP90 inhibitors: current development and potential in cancer therapy. Recent Pat Anticancer Drug Discov 2014;9:1–20.
   PubMed Web of Science ®Google Scholar
• Brandau S, Dresel A, Clos J. High constitutive levels of heat-shock proteins in human-pathogenic parasites of the genus Leishmania. Biochem J 1995;310:225–32.
   PubMed Web of Science ®Google Scholar
• Wiesgigl M, Clos J. Heat shock protein 90 homeostasis controls stage differentiation in Leishmania donovani. Mol Biol Cell 2001;12:3307–16.
   PubMed Web of Science ®Google Scholar
• Wiesgigl M, Clos J. The heat shock protein 90 of Leishmania donovani. Med Microbiol Immun 2001;190:27–31.
   PubMed Web of Science ®Google Scholar
• Shonhai A, Maier AG, Przyborski JM, Blatch GL. Intracellular protozoan parasites of humans: the role of molecular chaperones in development and pathogenesis. Protein Pept Lett 2011;18:143–57.
   PubMed Web of Science ®Google Scholar
• Larkin MA, Blackshields G, Brown NP, et al. Clustal W and Clustal X version 2.0. Bioinformatics 2007;23:2947–8.
   PubMed Web of Science ®Google Scholar
• Pizarro JC, Hills T, Senisterra G, et al. Exploring the Trypanosoma brucei Hsp83 potential as a target for structure guided drug design. PLoS Negl Trop Dis 2013;7:e2492.
   PubMed Web of Science ®Google Scholar
• Jacobson MP, Pincus DL, Rapp CS, et al. A hierarchical approach to all-atom protein loop prediction. Proteins 2004;55:351–67.
   PubMed Web of Science ®Google Scholar
• Case DA, Darden TA, Cheatham I, et al. AMBER 12. San Francisco: University of California; 2012.
   Google Scholar
• ROCS 3.2.0.4; OpenEye Scientific Software: Santa Fe, NM. http://www.eyesopen.com.
   Google Scholar
• Hawkins PC, Skillman AG, Nicholls A. Comparison of shape-matching and docking as virtual screening tools. J Med Chem 2007;50:74–82.
   PubMed Web of Science ®Google Scholar
• Hawkins PC, Skillman AG, Warren GL, et al. Conformer generation with OMEGA: algorithm and validation using high quality structures from the Protein Databank and Cambridge Structural Database. J Chem Inf Model 2010;50:572–84.
   PubMed Web of Science ®Google Scholar
• McGann M. FRED pose prediction and virtual screening accuracy. J Chem Inf Model 2011;51:578–96.
   PubMed Web of Science ®Google Scholar
• Schrödinger Release 2017-4: LigPrep, Schrödinger, LLC, New York, NY, 2017.
   Google Scholar
• Szybki 1.8.0.1 4; OpenEye Scientific Software: Santa Fe, NM. http://www.eyesopen.com.
   Google Scholar
• QUACPAC 1.6.3.1: OpenEye Scientific Software, Santa Fe, NM. http://www.eyesopen.com.
   Google Scholar
• Silva KP, Seraphim TV, Borges JC. Structural and functional studies of Leishmania braziliensis Hsp90. BBA-Proteins Proteom 2013;1834:351–61.
   PubMed Web of Science ®Google Scholar
• Minari K, de Azevedo EC, Kiraly VTR, et al. Thermodynamic analysis of interactions of the Hsp90 with adenosine nucleotides: a comparative perspective. Int J Biol Macromol 2019;130:125–38.
   PubMed Web of Science ®Google Scholar
• Batista FA, Gava LM, Pinheiro GM, et al. From conformation to interaction: techniques to explore the Hsp70/Hsp90 network. Curr Protein Pept Sci 2015;16:735–53.
   PubMed Web of Science ®Google Scholar
• Richter K, Muschler P, Hainzl O, Buchner J. Coordinated ATP hydrolysis by the Hsp90 dimer. J Biol Chem 2001;276:33689–96.
   PubMed Web of Science ®Google Scholar
• Roe SM, Prodromou C, O'Brien R, et al. Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin. J Med Chem 1999;42:260–6.
   PubMed Web of Science ®Google Scholar
• Palma LC, Ferreira L, Petersen A, et al. A docking-based structural analysis of geldanamycin-derived inhibitor binding to human or Leishmania Hsp90. Sci Rep-Uk 2019;9:14756.
   PubMed Web of Science ®Google Scholar
• Bhat R, Tummalapalli SR, Rotella DP. Progress in the discovery and development of heat shock protein 90 (Hsp90) inhibitors. J Med Chem 2014;57:8718–28.
   PubMed Web of Science ®Google Scholar
• Seraphim TV, Silva KP, Dores-Silva PR, et al. Insights on the structural dynamics of Leishmania braziliensis Hsp90 molecular chaperone by small angle X-ray scattering. Int J Biol Macromol 2017;97:503–12.
   PubMed Web of Science ®Google Scholar
• Li J, Soroka J, Buchner J. The Hsp90 chaperone machinery: conformational dynamics and regulation by co-chaperones. BBA-Mol Cell Res 2012;1823:624–35.
   PubMed Web of Science ®Google Scholar
• Ali MMU, Roe SM, Vaughan CK, et al. Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex. Nature 2006;440:1013–7.
   PubMed Web of Science ®Google Scholar
• Hessling M, Richter K, Buchner J. Dissection of the ATP-induced conformational cycle of the molecular chaperone Hsp90. Nat Struct Mol Biol 2009;16:287–93.
   PubMed Web of Science ®Google Scholar
• Pozzi C, Tassone G, Mangani S. X-ray crystallography contributions to drug discovery against parasite. Annu Rep Med Chem 2018;51:175–230.
   Web of Science ®Google Scholar